Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

Tag: pharma

Ally Bridge Backs Go-Private Deal of Chinese Pharmaceutical Firm Luoxin

Pan Yue -

CITIC M&A Fund, Legend Capital Lead $280M Investment In Pharmaron

Li Dongmei -

Hillhouse, CITIC PE-Backed BeiGene Files For US IPO

Investment Research Team -

ZY Investments To Jointly Launch $473M China Healthcare M&A Fund

Investment Research Team -

C-Bridge Capital Leads $35M New Round In Ascletis

Investment Research Team -

Shanghai Pharma Seeks $469M For Healthcare Venture Fund

Investment Research Team -

CITIC PE-Backed 3SBio Acquires Wansheng Pharma

Investment Research Team -

WuXi PharmaTech Unit To Raise $80M In New Funding

Investment Research Team -

CITIC PE-Backed 3SBio Seeks $712M Hong Kong IPO

Investment Research Team -

Fosun, Hopu Among Investors Acquiring Biotech Firm Ambrx

Jillian Yue -

Hony Capital Offloads CSPC Pharma Shares For $1.26B

Jillian Yue -

Qiming, TF Capital Lead $10M Series A In CANbridge Life Sciences

Investment Research Team -

BVCF Leads Series A Round For Shanghai Drug Maker CARsgen

Investment Research Team -

Blackstone To Acquire Stake In Xinrong Best Medical Instrument

Investment Research Team -

Baird Capital Exits Frontage Laboratories Through Trade Sale

Investment Research Team -

Cathay Capital Invest $24.5M In Kunming Shenghuo Pharma

Investment Research Team -
© 2021 China Money Network Limited. All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.